Kaken Pharmaceutical Dividends and Buybacks
Dividend criteria checks 5/6
Kaken Pharmaceutical is a dividend paying company with a current yield of 3.42% that is well covered by earnings.
Key information
3.4%
Dividend yield
-0.0006%
Buyback Yield
Total Shareholder Yield | 3.4% |
Future Dividend Yield | 3.4% |
Dividend Growth | 7.5% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | US$0.967 |
Payout ratio | 31% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: KKPC.F's dividends per share have been stable in the past 10 years.
Growing Dividend: KKPC.F's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
Kaken Pharmaceutical Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (KKPC.F) | 3.4% |
Market Bottom 25% (US) | 1.3% |
Market Top 25% (US) | 4.2% |
Industry Average (Pharmaceuticals) | 2.4% |
Analyst forecast (KKPC.F) (up to 3 years) | 3.4% |
Notable Dividend: KKPC.F's dividend (3.42%) is higher than the bottom 25% of dividend payers in the US market (1.37%).
High Dividend: KKPC.F's dividend (3.42%) is low compared to the top 25% of dividend payers in the US market (4.21%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (31.1%), KKPC.F's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (24.2%), KKPC.F's dividend payments are well covered by cash flows.